These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 30565334

  • 1. Factors associated with disease progression in dogs with presumed preclinical degenerative mitral valve disease attending primary care veterinary practices in the United Kingdom.
    Mattin MJ, Brodbelt DC, Church DB, Boswood A.
    J Vet Intern Med; 2019 Mar; 33(2):445-454. PubMed ID: 30565334
    [Abstract] [Full Text] [Related]

  • 2. Prognostic factors in dogs with presumed degenerative mitral valve disease attending primary-care veterinary practices in the United Kingdom.
    Mattin MJ, Boswood A, Church DB, Brodbelt DC.
    J Vet Intern Med; 2019 Mar; 33(2):432-444. PubMed ID: 30357909
    [Abstract] [Full Text] [Related]

  • 3. The combined prognostic potential of serum high-sensitivity cardiac troponin I and N-terminal pro-B-type natriuretic peptide concentrations in dogs with degenerative mitral valve disease.
    Hezzell MJ, Boswood A, Chang YM, Moonarmart W, Souttar K, Elliott J.
    J Vet Intern Med; 2012 Mar; 26(2):302-11. PubMed ID: 22369312
    [Abstract] [Full Text] [Related]

  • 4. Effect of Pimobendan on NT-proBNP and c troponin I before and after a submaximal exercise test in dogs with preclinical mitral valve disease without cardiomegaly - a randomised, double-blinded trial.
    Iwanuk N, Nolte I, Wall L, Sehn M, Raue J, Pilgram A, Rumstedt K, Bach JP.
    BMC Vet Res; 2019 Jul 09; 15(1):237. PubMed ID: 31288807
    [Abstract] [Full Text] [Related]

  • 5. Degenerative mitral valve disease: Survival of dogs attending primary-care practice in England.
    Mattin MJ, Boswood A, Church DB, McGreevy PD, O'Neill DG, Thomson PC, Brodbelt DC.
    Prev Vet Med; 2015 Dec 01; 122(4):436-42. PubMed ID: 26058819
    [Abstract] [Full Text] [Related]

  • 6. Accuracy of history, physical examination, cardiac biomarkers, and biochemical variables in identifying dogs with stage B2 degenerative mitral valve disease.
    Wilshaw J, Rosenthal SL, Wess G, Dickson D, Bevilacqua L, Dutton E, Deinert M, Abrantes R, Schneider I, Oyama MA, Gordon SG, Elliott J, Xia D, Boswood A.
    J Vet Intern Med; 2021 Mar 01; 35(2):755-770. PubMed ID: 33645846
    [Abstract] [Full Text] [Related]

  • 7. Plasma N-terminal pro-B-type natriuretic peptide concentration helps to predict survival in dogs with symptomatic degenerative mitral valve disease regardless of and in combination with the initial clinical status at admission.
    Serres F, Pouchelon JL, Poujol L, Lefebvre HP, Trumel C, Daste T, Sampedrano CC, Gouni V, Tissier R, Hawa G, Chetboul V.
    J Vet Cardiol; 2009 Dec 01; 11(2):103-21. PubMed ID: 19850546
    [Abstract] [Full Text] [Related]

  • 8. N-terminal pro B-type natriuretic peptide and left ventricular diameter independently predict mortality in dogs with mitral valve disease.
    Moonarmart W, Boswood A, Luis Fuentes V, Brodbelt D, Souttar K, Elliott J.
    J Small Anim Pract; 2010 Feb 01; 51(2):84-96. PubMed ID: 20070494
    [Abstract] [Full Text] [Related]

  • 9. Short-term hemodynamic and neuroendocrine effects of pimobendan and benazapril in dogs with myxomatous mitral valve disease and congestive heart failure.
    Häggström J, Lord PF, Höglund K, Ljungvall I, Jöns O, Kvart C, Hansson K.
    J Vet Intern Med; 2013 Feb 01; 27(6):1452-62. PubMed ID: 24128373
    [Abstract] [Full Text] [Related]

  • 10. Quality of Life Score as a Predictor of Death in Dogs with Degenerative Mitral Valve Disease.
    Strunz CMC, Marcondes-Santos M, Takada JY, Fragata FS, Mansur AP.
    Arq Bras Cardiol; 2017 Apr 01; 108(4):347-353. PubMed ID: 28380134
    [Abstract] [Full Text] [Related]

  • 11. Renal resistive index in 55 dogs with degenerative mitral valve disease.
    Chetboul V, Daste T, Gouni V, Concordet D, Trehiou-Sechi E, Serres F, Pouchelon JL, Germain CA, Layssol-Lamour C, Lefebvre HP.
    J Vet Intern Med; 2012 Apr 01; 26(1):101-8. PubMed ID: 22111692
    [Abstract] [Full Text] [Related]

  • 12. Brain-natriuretic peptide and cyclic guanosine monophosphate as biomarkers of myxomatous mitral valve disease in dogs.
    Moesgaard SG, Falk T, Teerlink T, Guðmundsdóttir HH, Sigurðardóttir S, Rasmussen CE, Olsen LH.
    Vet J; 2011 Sep 01; 189(3):349-52. PubMed ID: 20822939
    [Abstract] [Full Text] [Related]

  • 13. DELay of Appearance of sYmptoms of Canine Degenerative Mitral Valve Disease Treated with Spironolactone and Benazepril: the DELAY Study.
    Borgarelli M, Ferasin L, Lamb K, Bussadori C, Chiavegato D, D'Agnolo G, Migliorini F, Poggi M, Santilli RA, Guillot E, Garelli-Paar C, Toschi Corneliani R, Farina F, Zani A, Dirven M, Smets P, Guglielmini C, Oliveira P, Di Marcello M, Porciello F, Crosara S, Ciaramella P, Piantedosi D, Smith S, Vannini S, Dall'Aglio E, Savarino P, Quintavalla C, Patteson M, Silva J, Locatelli C, Baron Toaldo M.
    J Vet Cardiol; 2020 Feb 01; 27():34-53. PubMed ID: 32032923
    [Abstract] [Full Text] [Related]

  • 14. Biologic variability in NT-proBNP and cardiac troponin-I in healthy dogs and dogs with mitral valve degeneration.
    Ruaux C, Scollan K, Suchodolski JS, Steiner JM, Sisson DD.
    Vet Clin Pathol; 2015 Sep 01; 44(3):420-30. PubMed ID: 26108974
    [Abstract] [Full Text] [Related]

  • 15. Degenerative Valvular Disease in the Cavalier King Charles Spaniel: Results of the UK Breed Scheme 1991-2010.
    Swift S, Baldin A, Cripps P.
    J Vet Intern Med; 2017 Jan 01; 31(1):9-14. PubMed ID: 28054393
    [Abstract] [Full Text] [Related]

  • 16. How accurate are NT-proBNP, ANP, and cTnI levels in diagnosing dogs with myxomatous mitral valve disease?
    Chanmongkolpanit K, Riengvirodkij N, Channgam P, Kaenchan P, Buayam W, Janhirun Y, Phonarknguen R, Tansakul M, Sakcamduang W.
    Open Vet J; 2024 Jun 01; 14(6):1426-1441. PubMed ID: 39055758
    [Abstract] [Full Text] [Related]

  • 17. The diagnostic relevance of NT-proBNP and proANP 31-67 measurements in staging of myxomatous mitral valve disease in dogs.
    Wolf J, Gerlach N, Weber K, Klima A, Wess G.
    Vet Clin Pathol; 2013 Jun 01; 42(2):196-206. PubMed ID: 23614733
    [Abstract] [Full Text] [Related]

  • 18. N-Terminal Pro-B-Type Natriuretic Peptide and Phonocardiography in Differentiating Innocent Cardiac Murmurs from Congenital Cardiac Anomalies in Asymptomatic Puppies.
    Marinus SM, van Engelen H, Szatmári V.
    J Vet Intern Med; 2017 May 01; 31(3):661-667. PubMed ID: 28316101
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of new and old biomarkers in dogs with degenerative mitral valve disease.
    Klein S, Nolte I, Granados-Soler JL, Lietz P, Sehn M, Raue JF, Rohn K, Packeiser EM, Bach JP.
    BMC Vet Res; 2022 Jul 02; 18(1):256. PubMed ID: 35780161
    [Abstract] [Full Text] [Related]

  • 20. Prevalence of and risk factors for degenerative mitral valve disease in dogs attending primary-care veterinary practices in England.
    Mattin MJ, Boswood A, Church DB, López-Alvarez J, McGreevy PD, O'Neill DG, Thomson PC, Brodbelt DC.
    J Vet Intern Med; 2015 Jul 02; 29(3):847-54. PubMed ID: 25857638
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.